JPS5936620B2 - Method for producing 5-(α-haloalkanoyl)carbostyryl derivative - Google Patents

Method for producing 5-(α-haloalkanoyl)carbostyryl derivative

Info

Publication number
JPS5936620B2
JPS5936620B2 JP6824275A JP6824275A JPS5936620B2 JP S5936620 B2 JPS5936620 B2 JP S5936620B2 JP 6824275 A JP6824275 A JP 6824275A JP 6824275 A JP6824275 A JP 6824275A JP S5936620 B2 JPS5936620 B2 JP S5936620B2
Authority
JP
Japan
Prior art keywords
formula
haloalkanoyl
reference example
producing
carbostyryl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP6824275A
Other languages
Japanese (ja)
Other versions
JPS51143677A (en
Inventor
量之 中川
司郎 吉崎
薫 谷村
重晴 玉田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Otsuka Pharmaceutical Co Ltd
Original Assignee
Otsuka Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharmaceutical Co Ltd filed Critical Otsuka Pharmaceutical Co Ltd
Priority to JP6824275A priority Critical patent/JPS5936620B2/en
Publication of JPS51143677A publication Critical patent/JPS51143677A/en
Publication of JPS5936620B2 publication Critical patent/JPS5936620B2/en
Expired legal-status Critical Current

Links

Landscapes

  • Quinoline Compounds (AREA)

Description

【発明の詳細な説明】 技術分野 本発明は新規なる5−(α−ハロアルカノイル)カルボ
スチリル誘導体の製造法に関する。
DETAILED DESCRIPTION OF THE INVENTION Technical Field The present invention relates to a method for producing novel 5-(α-haloalkanoyl)carbostyryl derivatives.

発明の構成 本発明で得られる5−(α−ハロアルカノイル)カルボ
スチリル誘導体は一般式〔式中R、は水素原子を示し、
R3は水素原子又は炭素数1〜2個の低級アルキル基を
示し、R2は炭素数1〜2個の低級アルキル基又はアラ
ルキル基を示す。
Structure of the Invention The 5-(α-haloalkanoyl)carbostyryl derivative obtained in the present invention has the general formula [wherein R represents a hydrogen atom,
R3 represents a hydrogen atom or a lower alkyl group having 1 to 2 carbon atoms, and R2 represents a lower alkyl group or an aralkyl group having 1 to 2 carbon atoms.

またxはハロゲン原子を示す。〕で表わされる化合物で
ある。本発明の上記化合物は新規化合物であつて、β−
アドレナリン作働薬として、またβ−アドレナリン作働
神経興奮薬の合成中間体として有用である。本発明によ
り得られる化合物からの上記β−アドレナリン作働神経
興奮薬有効成分化合物の製造の詳細は後述する通りであ
る。本発明に係るカルボスチリル誘導体は一般式〔式中
R1及びR2は上記に同じ〕で表わされるカルボスチリ
ル誘導体と一般式〔式中R,及びXは上記に同じであり
、Xはハロゲン原子を示す。
Moreover, x represents a halogen atom. ] This is a compound represented by The above compound of the present invention is a new compound, and β-
It is useful as an adrenergic agonist and as an intermediate in the synthesis of β-adrenergic stimulants. Details of the production of the above-mentioned β-adrenergic stimulant active ingredient compound from the compound obtained according to the present invention are as described below. The carbostyryl derivative according to the present invention is a carbostyryl derivative represented by the general formula [wherein R1 and R2 are the same as above] and the general formula [wherein R and X are the same as above, and X represents a halogen atom] .

〕で表わされるα−ハロアルカン酸ハライドとを反応さ
せることにより得られる。
It can be obtained by reacting with an α-haloalkanoic acid halide represented by the following formula.

上記に於いてR2及びR3で示される炭素数1〜2個の
低級アルキル基としては、メチル及びエチル基が挙げら
れる。
In the above, examples of the lower alkyl group having 1 to 2 carbon atoms represented by R2 and R3 include methyl and ethyl groups.

またR2で示されるアラルキル基としては例えばベンジ
ル及びフエネチル基等が挙げられる。更にX.χで表わ
されるハロゲン原子としては例えば、塩素、臭素及び沃
素原子等が挙げられる。本発明に於いて一般式(1)で
表わされるカルボスチリル誘導体と一般式()で表わさ
れるα−ハロアルカン酸ハライドから本発明の5−(α
一ハロアルカノイル)カルボスチリル誘導体を得る反応
は一般にフリーデル・クラフツ反応と呼ばれるものであ
り、ルイス酸の存在下に行なわれる。
Examples of the aralkyl group represented by R2 include benzyl and phenethyl groups. Furthermore, X. Examples of the halogen atom represented by χ include chlorine, bromine, and iodine atoms. In the present invention, the 5-(α
The reaction for obtaining monohaloalkanoyl) carbostyril derivatives is generally called the Friedel-Crafts reaction, and is carried out in the presence of a Lewis acid.

この際使用されるルイス酸としては特に限定されないが
代表的なものとしては例えば、無水塩化アルミニウム、
塩化チタン等が挙げられる。之等ルイス酸の使用量は適
宜選択すれば良いが、通常一般式(1)で表わされるカ
ルボスチリル誘導体に対して1〜5倍モル(好ましくは
2〜4倍モル)用いられる。また一般式(1)で表わさ
れるカルボスチリル誘導体と一般式()で表わされるα
ーハロアルカン酸ハライドとの使用割合も適宜選択すれ
ばよいが、通常前者に対し後者を等倍モル〜大過剰(好
ましくは1.5〜5倍モル)を用いればよい。本反応は
無溶媒で反応させてもよく、また溶媒中で反応させても
よい。
The Lewis acid used at this time is not particularly limited, but representative examples include anhydrous aluminum chloride,
Examples include titanium chloride. The amount of the Lewis acid to be used may be selected as appropriate, but it is usually used in an amount of 1 to 5 times the mole (preferably 2 to 4 times) of the carbostyril derivative represented by the general formula (1). In addition, carbostyril derivatives represented by general formula (1) and α represented by general formula ()
The ratio of the haloalkanoic acid halide to the haloalkanoic acid halide may be selected as appropriate, but usually the latter may be used in an equal molar to large excess (preferably 1.5 to 5 molar) of the former. This reaction may be carried out without a solvent or in a solvent.

この際使用される溶媒としては、反応に関与しないもの
である限り特に限定されないが、通常二硫化炭素、ニト
ロベンゼン、メチレンクロライド、エチレンクロライド
等が有利に使用される。反応温度は特に限定されないが
一般に室温〜120℃(好ましくは50〜80℃)の問
が採用される。本反応により一般式(1)で表わされる
カルボスチリル誘導体の5位がα−ハロアルカノイル基
で置換された本発明の5−(α−ハロアルカノイル)カ
ルボスチリル誘導体が得られる。
The solvent used at this time is not particularly limited as long as it does not participate in the reaction, but carbon disulfide, nitrobenzene, methylene chloride, ethylene chloride, etc. are usually advantageously used. The reaction temperature is not particularly limited, but generally a range from room temperature to 120°C (preferably 50 to 80°C) is employed. This reaction yields the 5-(α-haloalkanoyl)carbostyryl derivative of the present invention in which the 5-position of the carbostyryl derivative represented by general formula (1) is substituted with an α-haloalkanoyl group.

かくして得られる本発明の化合物は、以下の反応行程式
に示す方法に従つて、β−アドレナリン作動神経興奮薬
有効成分化合物(一般式()及び()で示す化合物)に
誘導することができる。
The thus obtained compound of the present invention can be converted into a β-adrenergic stimulant active ingredient compound (compounds represented by general formulas () and ()) according to the method shown in the reaction scheme below.

く反応行程式〉〔式中R1〜R゛及びXは前記に同じ。Reaction Scheme> [In the formula, R1 to R' and X are the same as above.

R4は炭素数1〜4個のアルキル基を示す。〕上記反応
行程式に示す方法の詳細は、後記参考例1〜7に示す。
R4 represents an alkyl group having 1 to 4 carbon atoms. ] Details of the method shown in the above reaction scheme are shown in Reference Examples 1 to 7 below.

実施例 本発明を具体的に示すために実施例及び参考例を揚げる
EXAMPLES Examples and reference examples are provided to specifically illustrate the present invention.

実施例1 8−メトキシカルボスチリル10y)ニトロベンゼン1
5m1及びα−プロモブチリルブロマイド30yを混和
し、氷冷下無水塩化アルミニウム32yを徐々に加えた
後55〜60℃で4時間攪拌する。
Example 1 8-Methoxycarbostyryl 10y) Nitrobenzene 1
5ml and α-promobutyryl bromide 30y are mixed, and anhydrous aluminum chloride 32y is gradually added under ice cooling, followed by stirring at 55 to 60°C for 4 hours.

反応液を氷水200m1に注入し、生成する析出物をP
取次いでエタノール洗浄後メタノールより再結晶して融
点169〜170℃の5一(α−プロモブチリル)−8
−メトキシカルボスチリル11.5yを得る。実施例
2 8−メトキシカルボスチリル7V)クロロアセチルクロ
ライド9y及びニトロベンゼン10m1を混和し、氷冷
下無水塩化アルミニウム21yを徐徐に加えた後60〜
65℃で4時間撹拌する。
The reaction solution was poured into 200ml of ice water, and the precipitate formed was
Then, after washing with ethanol, recrystallization from methanol yields 5-(α-promobutyryl)-8 with a melting point of 169-170°C.
-Methoxycarbostyril 11.5y is obtained. Example
2 8-Methoxycarbostyryl 7V) After mixing 9y of chloroacetyl chloride and 10ml of nitrobenzene and gradually adding 21y of anhydrous aluminum chloride under ice cooling, 60~
Stir at 65°C for 4 hours.

反応液を氷水5007n1に注入し、生成する析出物を
沢取次いでエタノールで洗浄後タグノールより再結晶し
て融点243〜244℃の5−クロロアセチル−8−メ
トキシカルボスチリル8.5yを得る。実施例3 8−ベンジルオキシカルボスチリルとクロロアセチルク
ロライドとを上記実施例と同様に反応させて、融点27
5〜277℃の8−ベンジルオキシ−5−クロロアセチ
ルカルボスチリルを得る。
The reaction solution was poured into 5007n1 of ice water, the precipitate formed was collected, washed with ethanol, and then recrystallized from tagnol to obtain 8.5y of 5-chloroacetyl-8-methoxycarbostyryl having a melting point of 243-244°C. Example 3 8-benzyloxycarbostyryl and chloroacetyl chloride were reacted in the same manner as in the above example, and the melting point was 27.
Obtain 8-benzyloxy-5-chloroacetylcarbostyryl at 5-277°C.

参考例 1 実施例2で得た5−クロロアセチル−8−メトキシカル
ポスチリル3Vをイソプロパノール40TI12に溶解
し、60℃に加熱撹拌下、イソプロピルアミン107を
滴下して、2.5時間加熱撹拌し、溶媒を留去して1/
2量に濃縮後乾燥塩酸ガスを飽和させて析出物を沢取し
、エタノールから再結晶して、無色針状晶の5−イソプ
ロピルアミノアセチル−8−メトキシカルボスチリル塩
酸塩1.87を得る。
Reference Example 1 5-chloroacetyl-8-methoxycarpostyryl 3V obtained in Example 2 was dissolved in isopropanol 40TI12, and while heating and stirring at 60°C, isopropylamine 107 was added dropwise, followed by heating and stirring for 2.5 hours, Distill the solvent to 1/
After concentrating to 2 volumes, the precipitate was collected by saturation with dry hydrochloric acid gas and recrystallized from ethanol to obtain 1.87 g of 5-isopropylaminoacetyl-8-methoxycarbostyryl hydrochloride in the form of colorless needles.

参考例 2 5−イソプロピルアミノアセチル−8−メトキシカルボ
スチリル1.0tをメタノール50m1に溶解し氷冷下
攪拌しながら、水素化ほう素ナトリウム0.6tを少量
づつ加える。
Reference Example 2 1.0 t of 5-isopropylaminoacetyl-8-methoxycarbostyryl is dissolved in 50 ml of methanol, and while stirring under ice cooling, 0.6 t of sodium borohydride is added little by little.

添加終了後なお1時間攪拌をつづけ、次いで反応液を濃
塩酸でPH2〜3とし、析出物を沢去する。この沢液を
濃縮乾固して得られた残渣をアセトンから再結晶し次い
でエタノールから再結晶してMp23O〜231℃(分
解)、無色無定形の5−(1−ヒドロキシー2−イソプ
ロピルアミノ)エチル−8−メトキシカルボスチリル塩
酸塩1水和物0.87を得る。参考例 3 参考例1及び2と同様にして、実施例3で得た8−ベン
ジルオキシ−5−クロロアセチルカルボスチリルから、
8−ベンジルオキシ−5−(1一ヒドロキシ一2−イソ
プロピルアミノ)エチルカルボスチリルを得る。
After the addition was completed, stirring was continued for 1 hour, and then the reaction solution was adjusted to pH 2 to 3 with concentrated hydrochloric acid, and the precipitate was removed. The residue obtained by concentrating this solution to dryness was recrystallized from acetone and then recrystallized from ethanol to produce colorless and amorphous 5-(1-hydroxy-2-isopropylamino)ethyl 0.87 of -8-methoxycarbostyryl hydrochloride monohydrate is obtained. Reference Example 3 From 8-benzyloxy-5-chloroacetylcarbostyryl obtained in Example 3 in the same manner as Reference Examples 1 and 2,
8-Benzyloxy-5-(1-hydroxy-2-isopropylamino)ethylcarbostyryl is obtained.

Mp234〜236℃参考例 4 5−イソプロピルアミノアセチル−8−メトキシカルボ
スチリル2rに47%臭酸30m1を加え8時間加熱還
流する。
Mp234-236°C Reference Example 4 30 ml of 47% hydrochloric acid was added to 2r of 5-isopropylaminoacetyl-8-methoxycarbostyryl and heated under reflux for 8 hours.

水を加えながら3回濃縮乾固する。残渣を水60mjに
溶解し次いで炭酸ソーダ水溶液を加えてPH7とする。
析出結晶をP取し、塩酸で塩酸塩とした後、エタノール
より再結晶して融点288℃(分解点)の8−ヒドロキ
シー5−イソプロピルアミノアセチルカルボスチリル塩
酸塩水和物1.07を得る。参考例 5 上記参考例4で得た化合物に、参考例2と同様の操作を
行なうことにより、5−(1−ヒドロキシ−2−イソプ
ロピルアミノ)エチル−8−ヒドロキシカルボスチリル
塩酸塩を得る。
Concentrate to dryness three times while adding water. The residue was dissolved in 60 mj of water, and then an aqueous sodium carbonate solution was added to adjust the pH to 7.
The precipitated crystals are separated from P, converted into hydrochloride with hydrochloric acid, and then recrystallized from ethanol to obtain 8-hydroxy-5-isopropylaminoacetylcarbostyryl hydrochloride hydrate having a melting point of 288° C. (decomposition point) at 1.07. Reference Example 5 The compound obtained in Reference Example 4 above is subjected to the same operation as in Reference Example 2 to obtain 5-(1-hydroxy-2-isopropylamino)ethyl-8-hydroxycarbostyryl hydrochloride.

Mp2lO〜212ルC参考例 6 実施例1で得た5−(α−プロモブチリル)−8−メト
キシカルボスチリルに、参考例1、参考例4及び参考例
2の操作を行なうことにより、5一(1−ヒドロキシ−
2−イソプロピルアミノ)ブチル−8−ヒドロキシカル
ボスチリル塩酸塩を得る。
Mp2lO~212lC Reference Example 6 5-(α-promobutyryl)-8-methoxycarbostyryl obtained in Example 1 was subjected to the operations of Reference Example 1, Reference Example 4, and Reference Example 2 to obtain 5-( 1-hydroxy-
2-isopropylamino)butyl-8-hydroxycarbostyryl hydrochloride is obtained.

Mpl89〜190℃参考例 7 上記参考例6と同様にして、実施例3で得た化合物より
5−(1−ヒドロキシ−2−イソプロピルアミノ)エチ
ル−8−ヒドロキシカルボスチリル塩酸塩を得る。
Mpl89-190°C Reference Example 7 In the same manner as in Reference Example 6 above, 5-(1-hydroxy-2-isopropylamino)ethyl-8-hydroxycarbostyryl hydrochloride is obtained from the compound obtained in Example 3.

Mp2lO〜212℃次に上記参考例で得た化合物につ
き薬理試験を行つた結果を示す。
Mp21O~212°C Next, the results of a pharmacological test performed on the compound obtained in the above reference example are shown.

摘出モルモツト気管支試験 雄ハートレイ系モルモツト(体重450〜6007)よ
り気管を摘出し、コンスタンチンの方法〔J.W.CO
nstantine,,J.Pharm.Pharma
cOl.、17、384(1965)〕に従いスパイラ
ルに切つた。
Extracted guinea pig bronchus test The trachea was removed from a male Hartley guinea pig (body weight: 450 to 6,007 cm), and the method of Constantin [J. W. C.O.
nstantine,,J. Pharm. Pharma
cOl. 17, 384 (1965)].

標本を37±2℃、95%二酸化炭素−5%酸素ガスを
通気したロツク液(食塩154ミリモル、塩化カリウム
5.6ミリモル、塩化カルシウム2.2ミリモル、炭酸
水素ナトリウム2.4ミリモル、デキストロース5.6
ミリモル)15m1組織浴中に、2Vの負荷をかけて懸
垂した。標本の下端は固定し、上端は圧トランスデユー
サ一(三栄側器、45072型)に連結して、その張力
(弛緩)を等尺的に記録した。まず標本のα一受容体を
プロツクするために、予め上記組織液中にフエントール
アミンを3×1067/mlの濃度となるように加え、
次いでアセチルコリンを1×10−57/111の濃度
となるように加えて、標本を収縮させた。
The specimen was heated to 37±2°C in a lock solution (154 mmol of common salt, 5.6 mmol of potassium chloride, 2.2 mmol of calcium chloride, 2.4 mmol of sodium bicarbonate, 5 mmol of dextrose) with 95% carbon dioxide and 5% oxygen gas aerated. .6
The specimen was suspended in a 15 ml tissue bath with a load of 2 V applied. The lower end of the specimen was fixed, and the upper end was connected to a pressure transducer (Sanei Saigi, model 45072), and its tension (relaxation) was recorded isometrically. First, in order to block α-receptors in the specimen, phentolamine was added to the tissue fluid in advance to a concentration of 3 x 1067/ml.
Acetylcholine was then added to a concentration of 1 x 10-57/111 to shrink the specimen.

つづいて、バンロスムの方法〔J.M.anROssu
m.、Arch.Int.PharmacOdyn.T
her.、143、299(1963)〕に従い低濃度
より累積的に組織液中に試験薬物を投与した。
Continuing, Van Rossum's method [J. M. anROssu
m. , Arch. Int. PharmacOdyn. T
her. , 143, 299 (1963)], the test drug was cumulatively administered into the interstitial fluid at lower concentrations.

Claims (1)

【特許請求の範囲】 1 一般式 ▲数式、化学式、表等があります▼ 〔式中R_1は水素原子を示し、R_2は炭素数1〜2
個の低級アルキル基又はアラルキル基を示す。 〕で表わされるカルボスチリル誘導体と一般式▲数式、
化学式、表等があります▼〔式中R_3は水素原子又は
炭素数1〜2個の低級アルキル基を示し、X及びX′は
同一又は相異なつてハロゲン原子を示す。 〕で表わされるα−ハロアルカン酸ハライドとを反応さ
せることを特徴とする、一般式▲数式、化学式、表等が
あります▼ 〔式中R_1、R_2、R_3及びXは上記と同様の意
味を表わす。 〕で表わされる5−(α−ハロアルカノイル)カルボス
チリル誘導体の製造法。
[Claims] 1 General formula ▲ Numerical formula, chemical formula, table, etc. ▼ [In the formula, R_1 represents a hydrogen atom, and R_2 has 1 to 2 carbon atoms]
represents a lower alkyl group or an aralkyl group. ] Carbostyryl derivatives represented by the general formula ▲ mathematical formula,
Chemical formulas, tables, etc. are available▼ [In the formula, R_3 represents a hydrogen atom or a lower alkyl group having 1 to 2 carbon atoms, and X and X' are the same or different and represent a halogen atom. [In the formula, R_1, R_2, R_3 and X have the same meanings as above. ] A method for producing a 5-(α-haloalkanoyl)carbostyryl derivative.
JP6824275A 1975-06-05 1975-06-05 Method for producing 5-(α-haloalkanoyl)carbostyryl derivative Expired JPS5936620B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP6824275A JPS5936620B2 (en) 1975-06-05 1975-06-05 Method for producing 5-(α-haloalkanoyl)carbostyryl derivative

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP6824275A JPS5936620B2 (en) 1975-06-05 1975-06-05 Method for producing 5-(α-haloalkanoyl)carbostyryl derivative

Publications (2)

Publication Number Publication Date
JPS51143677A JPS51143677A (en) 1976-12-10
JPS5936620B2 true JPS5936620B2 (en) 1984-09-05

Family

ID=13368098

Family Applications (1)

Application Number Title Priority Date Filing Date
JP6824275A Expired JPS5936620B2 (en) 1975-06-05 1975-06-05 Method for producing 5-(α-haloalkanoyl)carbostyryl derivative

Country Status (1)

Country Link
JP (1) JPS5936620B2 (en)

Also Published As

Publication number Publication date
JPS51143677A (en) 1976-12-10

Similar Documents

Publication Publication Date Title
JP3803292B2 (en) Method for producing thiazolidine
US3282938A (en) 3-tertiary aminoloweralkyl-4-lower alkyl or phenyl-7-lower carbalkoxy lower alkyl or carboxy lower alkyl coumarins
JPH0681750B2 (en) Benzopyran derivative
CA1127642A (en) Process for the preparation of substituted 3-amino-sydnone-imines
US4783530A (en) 8-arylxanthines
CA1092111A (en) Sulfonamido-benzoic acid derivatives and process for the preparation thereof
ROEDER et al. Benzimidazole studies. I. The mechanism of benzimidazole formation from o-phenylenediamine
JPH0615529B2 (en) Novel piperidine derivative
JPS5913510B2 (en) Calbostyril Yudou Tainoseizohou
US3868377A (en) N-benzhydryl-N{40 -p-hydroxybenzyl-piperazines and processes for their manufacture
JPS597707B2 (en) Carbo Stiril Yudou Taino Seizouhou
JPS5936620B2 (en) Method for producing 5-(α-haloalkanoyl)carbostyryl derivative
US4474783A (en) Cyclopropylmethyl piperazines, the process for preparing the same and their use in therapeutics
US3959281A (en) Piperazino substituted coumarin derivatives
SE8107554L (en) NEW SUBSTITUTED DIMETOXICINAZOLINE DERIVATIVES
JPS5842195B2 (en) Method for producing thiazoloisoquinoline derivatives
JPH0425956B2 (en)
DK156396B (en) 2- (N-PYRROLIDINO) -3-ISOBUTOXY-N-SUBSTITUTED PHENYL-N-BENZYL-PROPYLAMINE COMPOUNDS AND PHARMACEUTICAL AGENTS CONTAINING THESE
JPS5832870A (en) Novel sydnone imine derivative and its preparation
US3467662A (en) 1-para-chlorophenyl-3-hydrazino - 1,5,6,7,8,8a-hexahydroimidazo(1,5-a)pyridine and process for its preparation
US3855224A (en) Basically substituted (1h,3h)-quinazoline-2-thion-4-one derivatives
JPS596866B2 (en) 5-((2-alkylamino-1-hydroxy)alkyl) carbostyril
US3772280A (en) Thiomorpholine-coumarin derivatives
JPS5825673B2 (en) Oxindole derivative
JPS596860B2 (en) Method for producing 5-[(2-alkylamino-1-hydroxy)alkyl]carbostyryl derivative